Skip to content
    K

    Kairos

    Kairos is a seed to Series A stage investment firm. It has made 28 investments. Their most common stage is series-a (46% of deals). Average disclosed round size is $22.6M (across 22 rounds with reported amounts).

    Find people at Kairos on Goldilocks AI

    Portfolio

    28

    Fund Size

    —

    Top Stage

    Series A

    Last 12 Mo

    0

    Portfolio Breakdown

    Stage Distribution

    Sector Distribution

    Investment Activity

    DealsAvg Round Size

    Portfolio

    35 investments
    CompanyRoundAmountDate
    Vivodyne logoVivodyneSeries A—May 2025
    Vivodyne logoVivodyneSeed—Nov 2023
    RRoslin TechSeries A—Nov 2022
    Materia Medica Processing logoMateria Medica ProcessingUnknown—Jan 2022
    RRoslin TechSeries A—Nov 2021
    Novosteo logoNovosteoSeries A$5.5MMar 2021
    Rhino logoRhinoUnknown$95MJan 2021
    Tulu logoTuluSeed—Jan 2021
    OrthoFX logoOrthoFXSeries A$13MJul 2020
    Foldax logoFoldaxSeries D$20MJan 2020
    Actuate Therapeutics logoActuate TherapeuticsSeries B$21.7MNov 2019
    Winnie logoWinnieSeries A$9MOct 2019
    Babysparks logoBabysparksSeed$2MJul 2019
    TTransient Plasma SystemsSeries A—Feb 2019
    Little Spoon logoLittle SpoonSeed$7MFeb 2019
    Kampaay logoKampaaySeries A$90KJan 2019
    Babysparks logoBabysparksSeed$2MJan 2019
    Foldax logoFoldaxUnknown$10.3MJan 2018
    IiBeatSeed$5.5MAug 2016
    Axial Biotherapeutics logoAxial BiotherapeuticsSeries A$19.1MJan 2016
    LogX logoLogXSeed$4M—
    Alomana logoAlomanaSeed$4.7M—
    MMyVillageSeed$6M—
    UUnderscore DistrictUnknown——
    DDolnai TechnologyUnknown——
    Page 1 of 2

    Top Co-Investors

    Last updated: 20 October 2026